SCHEMBL145506

SCHEMBL145506

CCCCc1ccc(OC)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.64
LMNA P02545 2/20 0.61
GAA P10253 2/20 0.61
MEN1 O00255 1/20 0.61
ALDH1A1 P00352 1/20 0.61
MAPT P10636 1/20 0.61
HPGD P15428 1/20 0.61
ALOX12 P18054 1/20 0.61
MAPK1 P28482 1/20 0.61
KMT2A Q03164 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
TAAR1 Q96RJ0 1/20 0.59
HTT P42858 1/20 0.58
IGF1R P08069 1/20 0.56
ALOX15 P16050 1/20 0.56
CASP3 P42574 1/20 0.56
SENP8 Q96LD8 1/20 0.56
SENP7 Q9BQF6 1/20 0.56
SENP6 Q9GZR1 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10569250 0.98 CALM1 (0.62) CALM1LMNAGAAMEN1ALDH1A1
Ammonia Solution, Strong SCHEMBL9169933 0.98 CALM1 (0.62) CALM1LMNAGAAMEN1ALDH1A1
SCHEMBL27914349 0.98 CALM1 (0.68) CALM1LMNAGAAMEN1ALDH1A1
SCHEMBL10571667 0.96 CALM1 (0.60) CALM1LMNAGAAMEN1ALDH1A1
SCHEMBL13579997 0.94 MAOB (0.63) CALM1LMNAGAAMEN1ALDH1A1
SCHEMBL581719 0.93 CASP3 (0.63) CALM1LMNAGAAMEN1ALDH1A1
SCHEMBL10568997 0.93 CASP3 (0.63) CALM1LMNAGAAMEN1ALDH1A1
SCHEMBL10534584 0.91 CASP3 (0.61) CALM1LMNAGAAMEN1ALDH1A1
SCHEMBL10571533 0.91 CASP3 (0.61) CALM1LMNAGAAMEN1ALDH1A1
SCHEMBL3220290 0.91 CASP3 (0.61) CALM1LMNAGAAMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 306 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240173227-A1 A FRAGRANCE MIXTURE CONTAINING ISOCITRONELLOL SYMRISE AG (DE) 2024-05-30 US claimed
CN-115385805-A Method for synthesizing dobutamine hydrochloride 广州仁恒医药科技股份有限公司 2022-11-25 CN claimed
CN-108026680-B Meltblown webs with improved properties 博里利斯股份公司 2020-12-08 CN claimed
CN-108739036-A A kind of high yield cultivating method of camellia oil 广西那坡县翠株园林业科技有限公司 2018-11-06 CN claimed
CN-101631807-B A cross-linking agent BOREALIS TECH OY FI 2013-05-29 CN claimed
US-8426115-B2 Patterning process and resist composition SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-04-23 US claimed
US-20110033803-A1 PATTERNING PROCESS AND RESIST COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-02-10 US claimed
US-20100159392-A1 PATTERNING PROCESS AND RESIST COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2010-06-24 US claimed
CN-101631807-A Linking agent BOREALIS TECH OY 2010-01-20 CN claimed
JP-2002522485-A 2002-07-23 JP claimed
EP-1109554-A2 PIPECOLIC ACID DERIVATIVES FOR VISION AND MEMORY DISORDERS GPI NIL Holdings, Inc. (US) 2001-06-27 EP claimed
WO-2000009109-A2 PIPECOLIC ACID DERIVATIVES FOR VISION AND MEMORY DISORDERS GPI NIL HOLDINGS, INC. (US) 2000-02-24 WO claimed
US-4707161-A Lightfastness of dyeings obtained with acid dyes or metal complex dyes on polyamides: treatment with copper hydroxamates BASF AKTIENGESELLSCHAFT (DE) 1987-11-17 US claimed
US-4473713-A Hydrolysis of aryl-aliphatic ethers RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1984-09-25 US claimed
EP-3626802-B1 METHOD FOR PRODUCING LIQUID COMPOSITION SUMITOMO CHEMICAL CO (JP) 2024-12-25 EP disclosed
EP-4419065-A1 FRAGRANCING COMPLEX, FRAGRANCING COMPOSITION AND FRAGRANCED AQUEOUS COMPOSITION OF NATURAL ORIGIN Expressions Parfumees (FR) 2024-08-28 EP disclosed
US-20240116965-A1 ORGANOMETALLIC COMPOUNDS UMICORE AG & CO. KG (DE) 2024-04-11 US disclosed
US-4029651-A ESTERIFICATION ELI LILLY AND COMPANY (US) 1977-06-14 US disclosed
US-4008231-A Preparation of 3-methoxymethylcephalosporins ELI LILLY AND COMPANY (US) 1977-02-15 US disclosed
US-4008230-A Process for preparing 3-hydroxy cephalosporins ELI LILLY AND COMPANY (US) 1977-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240116965-A1 ORGANOMETALLIC COMPOUNDS DDT, PPOX, PDCD2L CALM1 4523/4885LMNA 4472/4885GAA 3228/4885
US-20240173227-A1 A FRAGRANCE MIXTURE CONTAINING ISOCITRONELLOL IPO5, OR51E2, FDFT1 CALM1 3468/4885LMNA 3949/4885GAA 4689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.